Stefan Weber

09.01.2025 • News

Newron Licenses Evenamide to Myung In Pharm

Newron Pharmaceuticals, a central nervous system (CNS) focused biopharmaceutical company, and Myung In Pharm, South Korea’s leading CNS pharmaceutical company, today announced that they have entered into a license agreement to develop, manufacture, and commercialize Newron’s schizophrenia treatment evenamide.

Top-Feature

Evonik Industries AG

Maximize the Potential of Spent Hydroprocessing Catalysts

Ecocool GmbH

"transport logistic": Ecocool with packaging solutions for pharmaceutical transports — focus on sustainability and cargo monitoring

IMCD Deutschland GmbH

Fostering Innovation and Collaboration

greenCHEM

Future Prospects in Green Chemistry

Innovation Pitch

Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Myung in Pharm